Benzinga | Jul 30, 2021 10:03AM EDT

Canaccord Genuity Maintains Buy on Edwards Lifesciences, Raises Price Target to $124

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $103 to $124.